首页> 外文期刊>Biological & pharmaceutical bulletin >Panaxytriol Inhibits Lipopolysaccharide-Induced Microglia Activation in Brain Inflammation in Vivo
【24h】

Panaxytriol Inhibits Lipopolysaccharide-Induced Microglia Activation in Brain Inflammation in Vivo

机译:Panaxytriol抑制脂多糖诱导的体内脑炎症中的微胶质增生活化

获取原文
获取原文并翻译 | 示例
       

摘要

Brain inflammation is a pathological characteristic of neurodegenerative diseases. In this condition, excessively activated microglia elevate proinflammatory mediator levels. We previously reported that panaxytriol inhibited lipopolysaccharide (LPS)-induced microglia activation in vitro. However, the effects of panaxytriol on microglia activation in vivo require conlirmation. In the present study, we found that panaxytriol suppressed both microglia and astrocyte activation by injected LPS intracerebrally to mice with LPS-induced brain inflammation. Panaxytriol was more effective on microglia than astrocytes. Moreover, panaxytriol tended to reduce LPS-induced spontaneous motor activity dysfunction. These results suggested that panaxytriol could improve brain health by suppressing microglia activation in neurodegenerative diseases.
机译:脑炎症是神经变性疾病的病理特征。 在这种情况下,过度活化的微胶质细胞升高促炎介质水平。 我们之前据报道,Panaxytriol在体外抑制脂多糖(LPS)诱导的微胶质增生。 然而,Panaxytriol对体内微胶质增长的影响需要令人讨厌。 在本研究中,我们发现Panaxytriol通过LPS诱导的脑炎症注入小鼠的小鼠来抑制MICRIGLIA和星形胶质细胞活化。 Panaxytriol比星形胶质细胞更有效。 此外,Panaxytriol倾向于降低LPS诱导的自发电机活性功能障碍。 这些结果表明,白山氨基可以通过抑制神经变性疾病中的小凝血性活化来改善脑健康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号